Non-Invasive Blood Glucose Monitoring Devices Market, By Technology (EM Waves, Transdermal, Optical, and Enzymatic), By Modality (Wearable, Non-Wearable/Benchtop, and Embedded Devices), By End User (Hospitals, Clinics, and Homecare Setting), By Geography

Non-Invasive Blood Glucose Monitoring Devices Market, By Technology (EM Waves, Transdermal, Optical, and Enzymatic), By Modality (Wearable, Non-Wearable/Benchtop, and Embedded Devices), By End User (Hospitals, Clinics, and Homecare Setting), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

The global non-invasive blood glucose monitoring devices market was valued US$ 24.22 Mn in 2023 and is expected to reach US$ 77.63 Mn by 2031 growing at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.

Figure 1. Global Non-Invasive Blood Glucose Monitoring Devices Market Share (%), by Region, 2023

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics:

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global non-invasive blood glucose monitoring devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Detailed Segmentation:

• Global non-invasive blood glucose monitoring devices Market, By Technology:
• EM Waves
• Transdermal
• Optical
• Enzymatic
• Global non-invasive blood glucose monitoring devices Market, By Modality:
• Wearable
• Non-wearable/Benchtop
• Embedded Devices
• Global non-invasive blood glucose monitoring devices Market, By End User:
• Hospitals
• Clinics
• Homecare setting
• Global non-invasive blood glucose monitoring devices Market, By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
• Company Profile:
• Baxter International Inc.
• Dexcom, Inc
• Abbott
• Medtronic
• Senseonics Holdings, Inc
• GlySens Incorporated
• DiaMonTech GmbH
• Nemaura Medical Inc.
• Integrity Applications, Inc.
• CNOGA Medical Ltd.
• Breath Health, Inc.
• Metamaterial Technologies Inc.
• Opticology Inc.
• NovioSense BV
• Quick LLC
• RSP Systems A/S.